Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Revenue (2020 - 2025)

RxSight (RXST) has disclosed Revenue for 6 consecutive years, with $32.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 18.91% year-over-year to $32.6 million, compared with a TTM value of $134.5 million through Dec 2025, down 3.89%, and an annual FY2025 reading of $134.5 million, down 3.89% over the prior year.
  • Revenue was $32.6 million for Q4 2025 at RxSight, up from $30.3 million in the prior quarter.
  • Across five years, Revenue topped out at $40.2 million in Q4 2024 and bottomed at $3.5 million in Q1 2021.
  • Average Revenue over 5 years is $21.8 million, with a median of $21.5 million recorded in 2023.
  • The sharpest move saw Revenue soared 1791.97% in 2021, then fell 18.91% in 2025.
  • Year by year, Revenue stood at $8.4 million in 2021, then skyrocketed by 90.93% to $16.1 million in 2022, then surged by 77.64% to $28.6 million in 2023, then surged by 40.71% to $40.2 million in 2024, then dropped by 18.91% to $32.6 million in 2025.
  • Business Quant data shows Revenue for RXST at $32.6 million in Q4 2025, $30.3 million in Q3 2025, and $33.6 million in Q2 2025.